Loading clinical trials...
Loading clinical trials...
Patient Journey in Conventional Therapy for Primarily Treated Advanced Gynecologic Cancers in China
This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.
This is a mixed-methods survey study including a 2-phased sequential-explanatory design: Phase 1, Qualitative interview will be done first to explore the treatment decision factors, treatment experiences and unmet needs during post treatment surveillance, to provide components and inform the quantitative data collection. Phase 2, quantitative survey to collect data on a larger scale and allow a statistical generation of the qualitative findings.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Ying Zhou
Hefei, Anhui, China
Shuzhong Yao
Guangzhou, Guangdong, China
Gang Chen
Wuhan, Hubei, China
Dongling Zou
Chongqing, China
Start Date
July 1, 2025
Primary Completion Date
July 1, 2026
Completion Date
November 30, 2026
Last Updated
June 11, 2025
780
ESTIMATED participants
interview
OTHER
Lead Sponsor
Tongji Hospital
NCT04704661
NCT05039801
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions